Two researchers who study the debilitating sleep disorder have won a prestigious Lasker Award. Their research in animals laid the groundwork for a new drug that addresses the condition’s root cause.
OpenAI has selected its first international hospital partner, and it's in Israel. In this Newsmax Israel Update, Katrina Szish reports on OpenAI's new partnership with Sheba Medical Center, giving Israeli physicians access to advanced healthcare AI technology. Then, Israel correspondent Jodie Cohen visits the Pool of Siloam in Jerusalem, the ancient site associated with the biblical account of Jesus healing a blind man. Learn how a surprising discovery in 2004 helped uncover one of Jerusalem's most significant archaeological treasures and why excavations continue today. Watch, like, subscribe, and share for more reporting from Israel and around the world.
Moderna co-founder and board chairman Noubar Afeyan discusses the phase three success of the Moderna-Merck cancer vaccine trial and explains how the vaccine targets unique mutations to help prevent melanoma recurrence on ‘The Claman Countdown.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #moderna #merck #cancer #vaccine #health #medicine #medical #melanoma #science #research #trial #biotech #technology #treatment #breakthrough #healthcare #innovation
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
